Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-22-003919
Filing Date
2022-03-14
Accepted
2022-03-14 16:37:16
Documents
2
Period of Report
2022-03-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-55788.html 4  
1 PRIMARY DOCUMENT marketforms-55788.xml 4 5703
2 POA DOCUMENT poa.htm EX-24 3818
  Complete submission text file 0001214659-22-003919.txt   11006
Mailing Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078
Business Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078 (973) 200-3100
HUMANIGEN, INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address
Kilcoyne Adrian (Reporting) CIK: 0001857963 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 22737118